The Valley Desk

Clinical trial reportThe Lancet. OncologyPublished

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

15 of 45 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Penn Medicine, Penn Presbyterian Medical Center, University of Pennsylvania, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Lancet. Oncology
Published
Subject terms
Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Neoplasm Staging; Chemotherapy, Adjuvant; Nephrectomy; Aged; Middle Aged; Canada; Female; Male; Antineoplastic Agents, Immunological
PubMed ID
38942046
PubMed Central ID
PMC11323681
Added to directory
Source checked

Report a correction or request removal